A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis
Standard
A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis. / Galea, I; Lederer, C; Neuhaus, A; Muraro, P A; Scalfari, A; Koch-Henriksen, N; Heesen, C; Koepke, S; Stellmann, Jan-Patrick; Albrecht, H; Winkelmann, A; Weber, F; Bahn, E; Hauser, M; Edan, G; Ebers, G; Daumer, M.
In: EUR J NEUROL, Vol. 20, No. 7, 01.07.2013, p. 1107-9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis
AU - Galea, I
AU - Lederer, C
AU - Neuhaus, A
AU - Muraro, P A
AU - Scalfari, A
AU - Koch-Henriksen, N
AU - Heesen, C
AU - Koepke, S
AU - Stellmann, Jan-Patrick
AU - Albrecht, H
AU - Winkelmann, A
AU - Weber, F
AU - Bahn, E
AU - Hauser, M
AU - Edan, G
AU - Ebers, G
AU - Daumer, M
N1 - © 2012 The Author(s) European Journal of Neurology © 2012 EFNS.
PY - 2013/7/1
Y1 - 2013/7/1
N2 - BACKGROUND AND PURPOSE: The Evidence-Based Decision Support Tool in Multiple Sclerosis (EBDiMS) is the first web-based prognostic calculator in multiple sclerosis (MS) capable of delivering individualized estimates of disease progression. It has recently been extended to provide long-term predictions based on the data from a large natural history cohort.METHODS: We compared the predictive accuracy and consistency of EBDiMS with that of 17 neurologists highly specialized in MS.RESULTS: We show that whilst the predictive accuracy was similar, neurologists showed a significant intra-rater and inter-rater variability.CONCLUSIONS: Because EBDiMS was consistent, it is of superior utility in a specialist setting. Further field testing of EBDiMS in non-specialist settings, and investigation of its usefulness for counselling patients in treatment decisions, is warranted.
AB - BACKGROUND AND PURPOSE: The Evidence-Based Decision Support Tool in Multiple Sclerosis (EBDiMS) is the first web-based prognostic calculator in multiple sclerosis (MS) capable of delivering individualized estimates of disease progression. It has recently been extended to provide long-term predictions based on the data from a large natural history cohort.METHODS: We compared the predictive accuracy and consistency of EBDiMS with that of 17 neurologists highly specialized in MS.RESULTS: We show that whilst the predictive accuracy was similar, neurologists showed a significant intra-rater and inter-rater variability.CONCLUSIONS: Because EBDiMS was consistent, it is of superior utility in a specialist setting. Further field testing of EBDiMS in non-specialist settings, and investigation of its usefulness for counselling patients in treatment decisions, is warranted.
KW - Decision Support Systems, Clinical
KW - Humans
KW - Individualized Medicine
KW - Internet
KW - Multiple Sclerosis
KW - Neurology
KW - Observer Variation
KW - Prognosis
KW - Specialization
U2 - 10.1111/ene.12016
DO - 10.1111/ene.12016
M3 - SCORING: Journal article
C2 - 23379849
VL - 20
SP - 1107
EP - 1109
JO - EUR J NEUROL
JF - EUR J NEUROL
SN - 1351-5101
IS - 7
ER -